Clinical, epidemiological, and economic profile of patients with Parkinson disease eligible for neuromodulation
This cross-sectional study of 4,060 Parkinson's disease patients at a tertiary center reveals that 22% are eligible for neuromodulation and that the procedure offers significant clinical benefits alongside an estimated annual cost saving of R$ 8,247 per patient.